This article was originally published here
Sci Rep. 2021, April 16; 11 (1): 8386. doi: 10.1038 / s41598-021-88014-z.
ABSTRACT
Diabetes is linked to severe COVID-19 and...
Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...